Table of Contents [1–25 of 165 articles]

• Table of Contents for Year 2012
• Understanding and Prevention of “Therapy-” Induced Dyskinesias, Iciar Aviles-Olmos, Zinovia Kefalopoulou, and Thomas Foltynie
  Volume 2012 (2012), Article ID 640815, 9 pages
• A Possible Novel Anti-Inflammatory Mechanism for the Pharmacological Prolyl Hydroxylase Inhibitor 3,4-Dihydroxybenzoate: Implications for Use as a Therapeutic for Parkinson’s Disease, Shankar J. Chinta, Subramanian Rajagopalan, Abirami Ganesan, and Julie K. Andersen
  Volume 2012 (2012), Article ID 364684, 12 pages
• Patterns of Cell Activity in the Subthalamic Region Associated with the Neuroprotective Action of Near-Infrared Light Treatment in MPTP-Treated Mice, Victoria E. Shaw, Cassandra Peoples, Sharon Spana, Keyoumars Ashkan, Alim-Louis Benabid, Jonathan Stone, Gary E. Baker, and John Mitrofanis
  Volume 2012 (2012), Article ID 296875, 9 pages
• The Emerging Role of Proteolysis in Mitochondrial Quality Control and the Etiology of Parkinson’s Disease, Riya Shanbhag, Guang Shi, Jarungjit Rujiviphat, and G. Angus McQuibban
  Volume 2012 (2012), Article ID 382175, 16 pages
• Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia, Veronica Ghiglieri, Vincenza Bagetta, Valentina Pendolino, Barbara Picconi, and Paolo Calabresi
  Volume 2012 (2012), Article ID 358176, 10 pages
• The Prevalence of Fatigue Following Deep Brain Stimulation Surgery in Parkinson's Disease and Association with Quality of Life, Benzi M. Kluger, Veronica Parra, Charles Jacobson, Cynthia W. Garvan, Ramon L. Rodriguez, Hubert H. Fernandez, Amanda Fogel, Barry M. Skoblar, Dawn Bowers, and Michael S. Okun
  Volume 2012 (2012), Article ID 769506, 5 pages
• Magnolol Protects against MPTP/MPP⁺-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson’s Disease, Akiko Muroyama, Aya Fujita, Cheng Lv, Shota Kobayashi, Yoshiyasu Fukuyama, and Yasuhide Mitsumoto
  Volume 2012 (2012), Article ID 985157, 9 pages
• Metacognitive Performance, the Tip-of-Tongue Experience, Is Not Disrupted in Parkinsonian Patients, Justin D. Oh-Lee, Sarah M. Szymkowicz, Stefanie L. Smith, and Hajime Otani
  Volume 2012 (2012), Article ID 174079, 12 pages
• Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis, Simone A. van den Berge, Josta T. Kevenaar, Jacqueline A. Sluijs, and Elly M. Hol
  Volume 2012 (2012), Article ID 420957, 13 pages
• Neuropsychiatry of Parkinson's Disease, Antonio L. Teixeira, Leonardo F. Fontenelle, Edward C. Lauterbach, and Sergio Starkstein
  Volume 2012 (2012), Article ID 908943, 2 pages
• Dopamine Agonists and Pathologic Behaviors, Brendan J. Kelley, Andrew P. Duker, and Peter Chiu
  Volume 2012 (2012), Article ID 603631, 5 pages
• Genetic Rat Models of Parkinson's Disease, Ryan M. Welchko, Xavier T. Lévêque, and Gary L. Dunbar
  Volume 2012 (2012), Article ID 128356, 6 pages
• Rehabilitation and Parkinson’s Disease, Gammon M. Earhart, Terry Ellis, Alice Nieuwboer, and Leland E. Dibble
  Volume 2012 (2012), Article ID 371406, 3 pages
• Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study, Pascal. F. Durrenberger, Edna Grünblatt, Francesca S. Fernando, Camelia Maria Monoranu, Jordan Evans, Peter Riederer, Richard Reynolds, and David T. Dexter
  Volume 2012 (2012), Article ID 214714, 16 pages
• Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies, Kazunari Sekiyama, Shuei Sugama, Masayo Fujita, Akio Sekigawa, Yoshiki Takamatsu, Masaaki Waragai, Takato Takenouchi, and Makoto Hashimoto
  Volume 2012 (2012), Article ID 271732, 8 pages
• Gene Therapy for Parkinson's Disease, Rachel Denyer and Michael R. Douglas
  Volume 2012 (2012), Article ID 757305, 13 pages
• Web-Based Assessment of Visual and Visuospatial Symptoms in Parkinson’s Disease, Melissa M. Amick, Ivy N. Miller, Sandy Neargarder, and Alice Cronin-Golomb
  Volume 2012 (2012), Article ID 564812, 7 pages
• LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease, Cynthia Fox, Georg Ebersbach, Lorraine Ramig, and Shimon Sapir
  Volume 2012 (2012), Article ID 391946, 12 pages
• Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain, Alexandra Dumitriu, Carlee Moser, Tiffany C. Hadzi, Sally L. Williamson, Christopher D. Pacheco, Audrey E. Hendricks, Jeanne C. Latourelle, Jemma B. Wilk, Anita L. DeStefano, and Richard H. Myers
  Volume 2012 (2012), Article ID 614212, 8 pages
• Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based Therapy, Masaaki Kitada and Mari Dezawa
  Volume 2012 (2012), Article ID 873706, 9 pages
• Are Verbal Fluency and Nonliteral Language Comprehension Deficits Related to Depressive Symptoms in Parkinson’s Disease?, Christina Tremblay, Oury Monchi, Carol Hudon, Joël Macoir, and Laura Monetta
  Volume 2012 (2012), Article ID 308501, 8 pages
• Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease, John C. P. Piedad and Andrea E. Cavanna
  Volume 2012 (2012), Article ID 473769, 8 pages
• Improving Community Healthcare for Patients with Parkinson's Disease: The Dutch Model, S. H. J. Keus, L. B. Oude Nijhuis, M.J. Nijkrake, B. R. Bloem, and M. Munneke
  Volume 2012 (2012), Article ID 543426, 7 pages
• Altered Dynamic Postural Control during Step Turning in Persons with Early-Stage Parkinson’s Disease, Jooeun Song, Susan Sigward, Beth Fisher, and George J. Salem
  Volume 2012 (2012), Article ID 386962, 8 pages
• Risk of Falls in Parkinson’s Disease: A Cross-Sectional Study of 160 Patients, Ana Contreras and Francisco Grandas
  Volume 2012 (2012), Article ID 362572, 10 pages